磁共振成像用于乳腺瘤床勾画:与CT比较及序列差异
结果显示T1fs序列在放疗前和放疗结束时均显著降低观察者间变异,且T1fs上瘤床体积从放疗前18 cm³降至放疗结束时13 cm³(P < .01)。
要点
- T1fs序列较CT、T1、T2显著提高瘤床勾画一致性。
- 放疗结束时T1fs的CI显著高于T1和T2。
- T1fs上瘤床体积从18 cm³降至13 cm³(P < .01)。
核心结论
- T1fs序列在放疗前和放疗结束时均降低观察者间变异,并测得全乳放疗期间瘤床体积缩小。
研究设计与样本
- 两名观察者在CT和所有MR序列上勾画50个瘤床并分配腔隙可视化评分。
- 主要终点为观察者间变异,采用 conformity index(CI)评估。
主要发现
- 放疗前平均腔隙可视化评分:CT 3.14、T1 3.26、T1fs 3.41、T2 3.58。
- 放疗前平均CI:CT 0.65、T1 0.65、T1fs 0.72、T2 0.68。
- T1fs较CT、T1、T2显著改善观察者间变异(P < .001、P < .001、P = .011)。
- 放疗结束时T1fs的CI显著高于T1和T2(平均0.72、0.64、0.66;P < .001)。
- T1fs序列平均瘤床体积从放疗前18 cm³降至放疗结束时13 cm³(P < .01)。
临床怎么用
- T1fs快速序列可用于自适应推量或部分乳腺照射,尤其在MR直线加速器上。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to investigate the interobserver variability in breast tumor bed delineation using magnetic resonance (MR) compared with computed tomography (CT) at baseline and to quantify the change in tumor bed volume between pretreatment and end-of-treatment MR for patients undergoing whole breast radiation therapy. METHODS AND MATERIALS: Forty-eight patients with breast cancer planned for whole breast radiation therapy underwent CT and MR (T1, T1 fat-suppression [T1fs], and T2) simulation in the supine treatment position before radiation therapy and MR (T1, T1fs, and T2) at the end of treatment in the same position. Two observers delineated 50 tumor beds on the CT and all MR sequences and assigned cavity visualization scores to the images. The primary endpoint was interobserver variability, measured using the conformity index (CI). RESULTS: The mean cavity visualization scores at baseline were 3.14 (CT), 3.26 (T1), 3.41 (T1fs), and 3.58 (T2). The mean CIs were 0.65, 0.65, 0.72, and 0.68, respectively. T1fs significantly improved interobserver variability compared with CT, T1, or T2 (P < .001, P < .001, and P = .011, respectively). The CI for T1fs was significantly higher than T1 and T2 at the end of treatment (mean 0.72, 0.64, and 0.66, respectively; P < .001). The mean tumor bed volume on the T1fs sequence decreased from 18 cm3 at baseline to 13 cm3 at the end of treatment (P < .01). CONCLUSIONS: T1fs reduced interobserver variability on both pre- and end-of-treatment scans and measured a reduction in tumor bed volume during whole breast radiation therapy. This rapid sequence could be easily used for adaptive boost or partial breast irradiation, especially on MR linear accelerators.
引用
- Lowrey N, Koch CA, Purdie T, et al. Magnetic Resonance Imaging for Breast Tumor Bed Delineation: Computed Tomography Comparison and Sequence Variation. Adv Radiat Oncol. 2021. PMID: 34409213. doi:10.1016/j.adro.2021.100727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。